Startups

Leucid Bio logo

Leucid Bio

leucid.com

Develops engineered T-cell therapies for cancer, using its lateral CAR architecture to improve the performance of cellular immunotherapies.

Team

Belinda CarlsenVP of Clinical Operations
Filippo PettiCEO
Heikki LancrietNon-Executive Director
Ian MiscampbellBoard Chairman
John MaherCSO
Marc DaviesVP of Research and Development
Mark DochertyCFO and COO
Martin DiggleNon-Executive Director
Peter FinanNon-Executive Director

Investments

$—Unknown dateVulpes
$—Unknown dateEpidarex Capital